Global Sickle-cell Anemia Therapeutics Market Size, Status and Forecast 2021-2027

Global Sickle-cell Anemia Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle-cell Anemia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Transfusion
1.2.3 Pharmacotherapy
1.2.4 Bone Marrow Transplant
1.3 Market by Application
1.3.1 Global Sickle-cell Anemia Therapeutics Market Share by User: 2016 VS 2021 VS 2027
1.3.2 Child
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sickle-cell Anemia Therapeutics Market Perspective (2016-2027)
2.2 Sickle-cell Anemia Therapeutics Growth Trends by Regions
2.2.1 Sickle-cell Anemia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sickle-cell Anemia Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Sickle-cell Anemia Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Sickle-cell Anemia Therapeutics Industry Dynamic
2.3.1 Sickle-cell Anemia Therapeutics Market Trends
2.3.2 Sickle-cell Anemia Therapeutics Market Drivers
2.3.3 Sickle-cell Anemia Therapeutics Market Challenges
2.3.4 Sickle-cell Anemia Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sickle-cell Anemia Therapeutics Players by Revenue
3.1.1 Global Top Sickle-cell Anemia Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Sickle-cell Anemia Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Sickle-cell Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sickle-cell Anemia Therapeutics Revenue
3.4 Global Sickle-cell Anemia Therapeutics Market Concentration Ratio
3.4.1 Global Sickle-cell Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle-cell Anemia Therapeutics Revenue in 2020
3.5 Sickle-cell Anemia Therapeutics Key Players Head office and Area Served
3.6 Key Players Sickle-cell Anemia Therapeutics Product Solution and Service
3.7 Date of Enter into Sickle-cell Anemia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle-cell Anemia Therapeutics Breakdown Data by Type
4.1 Global Sickle-cell Anemia Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Sickle-cell Anemia Therapeutics Forecasted Market Size by Type (2022-2027)
5 Sickle-cell Anemia Therapeutics Breakdown Data by User
5.1 Global Sickle-cell Anemia Therapeutics Historic Market Size by User (2016-2021)
5.2 Global Sickle-cell Anemia Therapeutics Forecasted Market Size by User (2022-2027)
6 North America
6.1 North America Sickle-cell Anemia Therapeutics Market Size (2016-2027)
6.2 North America Sickle-cell Anemia Therapeutics Market Size by Type
6.2.1 North America Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Sickle-cell Anemia Therapeutics Market Size by Type (2016-2027)
6.3 North America Sickle-cell Anemia Therapeutics Market Size by User
6.3.1 North America Sickle-cell Anemia Therapeutics Market Size by User (2016-2021)
6.3.2 North America Sickle-cell Anemia Therapeutics Market Size by User (2022-2027)
6.3.3 North America Sickle-cell Anemia Therapeutics Market Size by User (2016-2027)
6.4 North America Sickle-cell Anemia Therapeutics Market Size by Country
6.4.1 North America Sickle-cell Anemia Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Sickle-cell Anemia Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Sickle-cell Anemia Therapeutics Market Size (2016-2027)
7.2 Europe Sickle-cell Anemia Therapeutics Market Size by Type
7.2.1 Europe Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Sickle-cell Anemia Therapeutics Market Size by Type (2016-2027)
7.3 Europe Sickle-cell Anemia Therapeutics Market Size by User
7.3.1 Europe Sickle-cell Anemia Therapeutics Market Size by User (2016-2021)
7.3.2 Europe Sickle-cell Anemia Therapeutics Market Size by User (2022-2027)
7.3.3 Europe Sickle-cell Anemia Therapeutics Market Size by User (2016-2027)
7.4 Europe Sickle-cell Anemia Therapeutics Market Size by Country
7.4.1 Europe Sickle-cell Anemia Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Sickle-cell Anemia Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by User
8.3.1 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by User (2016-2021)
8.3.2 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by User (2022-2027)
8.3.3 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by User (2016-2027)
8.4 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sickle-cell Anemia Therapeutics Market Size (2016-2027)
9.2 Latin America Sickle-cell Anemia Therapeutics Market Size by Type
9.2.1 Latin America Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Sickle-cell Anemia Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Sickle-cell Anemia Therapeutics Market Size by User
9.3.1 Latin America Sickle-cell Anemia Therapeutics Market Size by User (2016-2021)
9.3.2 Latin America Sickle-cell Anemia Therapeutics Market Size by User (2022-2027)
9.3.3 Latin America Sickle-cell Anemia Therapeutics Market Size by User (2016-2027)
9.4 Latin America Sickle-cell Anemia Therapeutics Market Size by Country
9.4.1 Latin America Sickle-cell Anemia Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Sickle-cell Anemia Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by User
10.3.1 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by User (2016-2021)
10.3.2 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by User (2022-2027)
10.3.3 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by User (2016-2027)
10.4 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Addmedica
11.1.1 Addmedica Company Details
11.1.2 Addmedica Business Overview
11.1.3 Addmedica Sickle-cell Anemia Therapeutics Introduction
11.1.4 Addmedica Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.1.5 Addmedica Recent Development
11.2 Gamida Cell
11.2.1 Gamida Cell Company Details
11.2.2 Gamida Cell Business Overview
11.2.3 Gamida Cell Sickle-cell Anemia Therapeutics Introduction
11.2.4 Gamida Cell Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.2.5 Gamida Cell Recent Development
11.3 GlycoMimetics
11.3.1 GlycoMimetics Company Details
11.3.2 GlycoMimetics Business Overview
11.3.3 GlycoMimetics Sickle-cell Anemia Therapeutics Introduction
11.3.4 GlycoMimetics Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.3.5 GlycoMimetics Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Sickle-cell Anemia Therapeutics Introduction
11.4.4 Pfizer Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Sickle-cell Anemia Therapeutics Introduction
11.5.4 Novartis Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Global Blood Therapeutics
11.6.1 Global Blood Therapeutics Company Details
11.6.2 Global Blood Therapeutics Business Overview
11.6.3 Global Blood Therapeutics Sickle-cell Anemia Therapeutics Introduction
11.6.4 Global Blood Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.6.5 Global Blood Therapeutics Recent Development
11.7 Micelle BioPharma
11.7.1 Micelle BioPharma Company Details
11.7.2 Micelle BioPharma Business Overview
11.7.3 Micelle BioPharma Sickle-cell Anemia Therapeutics Introduction
11.7.4 Micelle BioPharma Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.7.5 Micelle BioPharma Recent Development
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Details
11.8.2 Bluebird Bio Business Overview
11.8.3 Bluebird Bio Sickle-cell Anemia Therapeutics Introduction
11.8.4 Bluebird Bio Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.8.5 Bluebird Bio Recent Development
11.9 Prolong Pharmaceuticals
11.9.1 Prolong Pharmaceuticals Company Details
11.9.2 Prolong Pharmaceuticals Business Overview
11.9.3 Prolong Pharmaceuticals Sickle-cell Anemia Therapeutics Introduction
11.9.4 Prolong Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.9.5 Prolong Pharmaceuticals Recent Development
11.10 Modus Therapeutics
11.10.1 Modus Therapeutics Company Details
11.10.2 Modus Therapeutics Business Overview
11.10.3 Modus Therapeutics Sickle-cell Anemia Therapeutics Introduction
11.10.4 Modus Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.10.5 Modus Therapeutics Recent Development
11.11 Sangamo Biosciences
11.11.1 Sangamo Biosciences Company Details
11.11.2 Sangamo Biosciences Business Overview
11.11.3 Sangamo Biosciences Sickle-cell Anemia Therapeutics Introduction
11.11.4 Sangamo Biosciences Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.11.5 Sangamo Biosciences Recent Development
11.12 Bioverativ
11.12.1 Bioverativ Company Details
11.12.2 Bioverativ Business Overview
11.12.3 Bioverativ Sickle-cell Anemia Therapeutics Introduction
11.12.4 Bioverativ Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.12.5 Bioverativ Recent Development
11.13 Imara
11.13.1 Imara Company Details
11.13.2 Imara Business Overview
11.13.3 Imara Sickle-cell Anemia Therapeutics Introduction
11.13.4 Imara Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.13.5 Imara Recent Development
11.14 Ironwood Pharmaceuticals
11.14.1 Ironwood Pharmaceuticals Company Details
11.14.2 Ironwood Pharmaceuticals Business Overview
11.14.3 Ironwood Pharmaceuticals Sickle-cell Anemia Therapeutics Introduction
11.14.4 Ironwood Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021)
11.14.5 Ironwood Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Sickle-cell Anemia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Blood Transfusion
Table 3. Key Players of Pharmacotherapy
Table 4. Key Players of Bone Marrow Transplant
Table 5. Global Sickle-cell Anemia Therapeutics Market Size Growth by User (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Sickle-cell Anemia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Sickle-cell Anemia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Sickle-cell Anemia Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Sickle-cell Anemia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Sickle-cell Anemia Therapeutics Market Share by Regions (2022-2027)
Table 11. Sickle-cell Anemia Therapeutics Market Trends
Table 12. Sickle-cell Anemia Therapeutics Market Drivers
Table 13. Sickle-cell Anemia Therapeutics Market Challenges
Table 14. Sickle-cell Anemia Therapeutics Market Restraints
Table 15. Global Sickle-cell Anemia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Sickle-cell Anemia Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Sickle-cell Anemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle-cell Anemia Therapeutics as of 2020)
Table 18. Ranking of Global Top Sickle-cell Anemia Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Sickle-cell Anemia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sickle-cell Anemia Therapeutics Product Solution and Service
Table 22. Date of Enter into Sickle-cell Anemia Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Sickle-cell Anemia Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Sickle-cell Anemia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Sickle-cell Anemia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Sickle-cell Anemia Therapeutics Market Size Share by User (2016-2021) & (US$ Million)
Table 29. Global Sickle-cell Anemia Therapeutics Revenue Market Share by User (2016-2021)
Table 30. Global Sickle-cell Anemia Therapeutics Forecasted Market Size by User (2022-2027) (US$ Million)
Table 31. Global Sickle-cell Anemia Therapeutics Revenue Market Share by User (2022-2027) & (US$ Million)
Table 32. North America Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Sickle-cell Anemia Therapeutics Market Size by User (2016-2021) (US$ Million)
Table 35. North America Sickle-cell Anemia Therapeutics Market Size by User (2022-2027) & (US$ Million)
Table 36. North America Sickle-cell Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Sickle-cell Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Sickle-cell Anemia Therapeutics Market Size by User (2016-2021) (US$ Million)
Table 41. Europe Sickle-cell Anemia Therapeutics Market Size by User (2022-2027) & (US$ Million)
Table 42. Europe Sickle-cell Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Sickle-cell Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by User (2016-2021) (US$ Million)
Table 47. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by User (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Sickle-cell Anemia Therapeutics Market Size by User (2016-2021) (US$ Million)
Table 53. Latin America Sickle-cell Anemia Therapeutics Market Size by User (2022-2027) & (US$ Million)
Table 54. Latin America Sickle-cell Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Sickle-cell Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by User (2016-2021) (US$ Million)
Table 59. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by User (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Addmedica Company Details
Table 63. Addmedica Business Overview
Table 64. Addmedica Sickle-cell Anemia Therapeutics Product
Table 65. Addmedica Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Addmedica Recent Development
Table 67. Gamida Cell Company Details
Table 68. Gamida Cell Business Overview
Table 69. Gamida Cell Sickle-cell Anemia Therapeutics Product
Table 70. Gamida Cell Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Gamida Cell Recent Development
Table 72. GlycoMimetics Company Details
Table 73. GlycoMimetics Business Overview
Table 74. GlycoMimetics Sickle-cell Anemia Therapeutics Product
Table 75. GlycoMimetics Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 76. GlycoMimetics Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Sickle-cell Anemia Therapeutics Product
Table 80. Pfizer Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Sickle-cell Anemia Therapeutics Product
Table 85. Novartis Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Global Blood Therapeutics Company Details
Table 88. Global Blood Therapeutics Business Overview
Table 89. Global Blood Therapeutics Sickle-cell Anemia Therapeutics Product
Table 90. Global Blood Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Global Blood Therapeutics Recent Development
Table 92. Micelle BioPharma Company Details
Table 93. Micelle BioPharma Business Overview
Table 94. Micelle BioPharma Sickle-cell Anemia Therapeutics Product
Table 95. Micelle BioPharma Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Micelle BioPharma Recent Development
Table 97. Bluebird Bio Company Details
Table 98. Bluebird Bio Business Overview
Table 99. Bluebird Bio Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Bluebird Bio Recent Development
Table 101. Prolong Pharmaceuticals Company Details
Table 102. Prolong Pharmaceuticals Business Overview
Table 103. Prolong Pharmaceuticals Sickle-cell Anemia Therapeutics Product
Table 104. Prolong Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Prolong Pharmaceuticals Recent Development
Table 106. Modus Therapeutics Company Details
Table 107. Modus Therapeutics Business Overview
Table 108. Modus Therapeutics Sickle-cell Anemia Therapeutics Product
Table 109. Modus Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Modus Therapeutics Recent Development
Table 111. Sangamo Biosciences Company Details
Table 112. Sangamo Biosciences Business Overview
Table 113. Sangamo Biosciences Sickle-cell Anemia Therapeutics Product
Table 114. Sangamo Biosciences Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 115. Sangamo Biosciences Recent Development
Table 116. Bioverativ Company Details
Table 117. Bioverativ Business Overview
Table 118. Bioverativ Sickle-cell Anemia Therapeutics Product
Table 119. Bioverativ Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 120. Bioverativ Recent Development
Table 121. Imara Company Details
Table 122. Imara Business Overview
Table 123. Imara Sickle-cell Anemia Therapeutics Product
Table 124. Imara Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 125. Imara Recent Development
Table 126. Ironwood Pharmaceuticals Company Details
Table 127. Ironwood Pharmaceuticals Business Overview
Table 128. Ironwood Pharmaceuticals Sickle-cell Anemia Therapeutics Product
Table 129. Ironwood Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 130. Ironwood Pharmaceuticals Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sickle-cell Anemia Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Blood Transfusion Features
Figure 3. Pharmacotherapy Features
Figure 4. Bone Marrow Transplant Features
Figure 5. Global Sickle-cell Anemia Therapeutics Market Share by User: 2020 VS 2027
Figure 6. Child Case Studies
Figure 7. Adult Case Studies
Figure 8. Sickle-cell Anemia Therapeutics Report Years Considered
Figure 9. Global Sickle-cell Anemia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Sickle-cell Anemia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Sickle-cell Anemia Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Sickle-cell Anemia Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Sickle-cell Anemia Therapeutics Market Share by Players in 2020
Figure 14. Global Top Sickle-cell Anemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle-cell Anemia Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Sickle-cell Anemia Therapeutics Revenue in 2020
Figure 16. Global Sickle-cell Anemia Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Sickle-cell Anemia Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Sickle-cell Anemia Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Sickle-cell Anemia Therapeutics Market Share by User (2016-2027)
Figure 21. North America Sickle-cell Anemia Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Sickle-cell Anemia Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Sickle-cell Anemia Therapeutics Market Share by User (2016-2027)
Figure 27. Europe Sickle-cell Anemia Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Sickle-cell Anemia Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Sickle-cell Anemia Therapeutics Market Share by User (2016-2027)
Figure 37. Asia-Pacific Sickle-cell Anemia Therapeutics Market Share by Region (2016-2027)
Figure 38. China Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Sickle-cell Anemia Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Sickle-cell Anemia Therapeutics Market Share by User (2016-2027)
Figure 47. Latin America Sickle-cell Anemia Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Sickle-cell Anemia Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Sickle-cell Anemia Therapeutics Market Share by User (2016-2027)
Figure 53. Middle East & Africa Sickle-cell Anemia Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Sickle-cell Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Addmedica Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 58. Gamida Cell Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 59. GlycoMimetics Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 62. Global Blood Therapeutics Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 63. Micelle BioPharma Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 64. Bluebird Bio Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 65. Prolong Pharmaceuticals Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 66. Modus Therapeutics Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 67. Sangamo Biosciences Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 68. Bioverativ Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 69. Imara Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 70. Ironwood Pharmaceuticals Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Fibrinogen Concentrate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......

Global Fibrinogen Concentrate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91

According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......

Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124

Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......

Global Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......

Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......

Global Low Molecular Weight Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......

Global Heparin Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......

Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......

Global Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs